1. Neural transplantation in Huntington's diseased patients is currently the only approach in the treatment of this neurodegenerative disorder. The clinical trial, unfortunately, includes only a small number of patients until now, since many important questions have not been answered yet. One of them is only mild to moderate improvement of the state in most of grafted patients. 2. We examined the morphological correlates in the response to intrastriatal grafting of fragments of foetal rat ventral mesencephalic tissue 1 month after transplantation in male Wistar rats within varying durations (from 2 to 38 weeks) of experimentally induced neurodegenerative process of the striatum (used as a model of Huntington's disease). Our goal was to determine the impact of advanced striatal damage and gliosis on the graft viability and host-graft integration. 3. The findings can be summarized as follows: The progressive reactive gliosis, which is not able to compensate continual reduction of the grey matter leading to an extensive atrophy of the striatum in a long-term lesions, results in formation of the compact glial network. This tissue cannot be considered the suitable terrain for successful graft development and formation of host-graft interconnections. 4. The progression of irreversible morphological changes in long-lasting neurodegenerative process within the striatum can be supposed one of the important factors, which may decrease our prospect of distinct improvement after neural grafting in patients in advanced stage of Huntington's disease, who still remain the leading group in clinical trials.

Department of Histology and Embryology Charles University Prague Faculty of Medicine in Hradec Králové Hradec Králové Czech Republic

Zobrazit více v PubMed

Bachoud-Lévi, A. C., Bourdet, C., Brugieres, P., Nguyen, J. P., Grandmougin, T., Haddad, B., Jeny, R., Bartolomeo, P., Boisse, M. F., Barba, G. D., Degos, J. D., Ergis, A. M., Lefaucheur, J. P., Lisovoski, F., Pailhous, E., Remy, P., Palfi, S., Defer, G. L., Césaro, P., Hantraye, P., and Peschanski, M. (2000). Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington’s disease. Exp. Neurol.161:194–202. PubMed

Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Schwartz, K. J., and Martin, J. B. (1986). Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature321:168–171. PubMed

Björklund, H., Olson, L., Dahl, D., and Schwarcz, R. (1986). Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes. Brain Res.371:267–277. PubMed

Brasted, P. J., Robbins, T. W., and Dunnett, S. B. (2000). Behavioral recovery following transplantation into a rat model of Huntington's disease requires both anatomical connectivity and extensive postoperative training. Proc. Natl. Acad. Sci. USA114:431–436. PubMed

Cheng, H. W., Jiang, T., Brown, S. A., Pasinetti, G. M., Finch, C. E., and McNeil, T. H. (1994). Response of striatal astrocytes to neuronal deafferentation: an immunocytochemical and ultrastructural study. Neuroscience62:425–439. PubMed

Collier, T. J., Sortwell, C. E., and Daley, B. F. (1999). Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J. Neurosci.19(13):5563–5573. PubMed PMC

Coyle, J. T., and Schwarcz, R. (1976). Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature263:244–246. PubMed

DiFiglia, M., Schiff, L., and Deckel, A. W. (1988). Neuronal organization of fetal striatal grafts in kainate- and sham-lesioned rat caudate nucleus: light- and electron-microscopic observations. J. Neurosci.8:1112–1130. PubMed PMC

Dunnett, S. B., and Björklund, A. (1992). Staging and dissection of rat embryos. In Dunnett, S. B., and Björklund, A. (eds.) Neural Transplantation: A Practical Approach, Oxford University Press, Oxford, pp. 1–19.

Dusart, I., Marty, S., and Peschanski, M. (1991). Glial changes following an excitotoxic lesion in the CNS-II. Astrocyt. Neurosci.45:541–549. PubMed

Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E., and Beal, M. F. (1993). Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol.119:46–71. PubMed

Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W. Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., Eidelberg, D., and Fahn, S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med.344(10):710–719. PubMed

Gates, M. A., Laywell, E. D., Fillmore, H., and Steindler, D. A. (1996). Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence. Neuroscience74(2):579–597. PubMed

Groves, M., Vonsattel, J. P., Mazzoni, P., and Marder, K. (2003). Huntington's disease. Sci. Aging Knowl. Environ.43:1–14. PubMed

Isacson, O., Brundin, P., Gage, F. H., and Björklund, A. (1985). Neural grafting in a rat model of Huntington's disease: Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience16:799–817. PubMed

Isacson, O., Fischer, W., Wictorin, K., Dawbarn, D., and Björklund, A. (1987). Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience20:1043–1056. PubMed

Isacson, O., Hantraye, P., Riche, D., Schumacher, J. M., and Mazière, M. (1991). The relationship between symptoms and functional anatomy in the chronic neurodegenerative diseases: From pharmacological to biological replacement therapy in Huntington's disease. In Lindvall, O., Björklund, A., and Widner, H. (eds.) Intracerebral Transplantation in Movement Disorders, Elsevier, Amsterdam, pp. 245–258.

Jabs, R., Bekar, L. K., and Walz, W. (1998). Reactive astrogliosis in the injured and postischemic brain. In Walz, W. (ed.) Cerebral Ischemia: Molecular and Cellular Pathophysiology, Humana Press Inc., Totowa, pp. 233–249.

Kimelberg, H. K. (2004). The problem of astrocyte identity. Neurochem. Int.45:191–202. PubMed

Kopyov, O. V., Jacques, S., Lieberman, A., Duma, C. M., and Eagle, K. S. (1998). Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol.149:97–108. PubMed

Leegwater-Kim, J., and Cha, J. H. (2004). The paradigm of Huntington's disease: Therapeutic opportunities in neurodegeneration. NeuroRx1(1):128–138. PubMed PMC

Liu, F. Ch., Graybiel, A. M., Dunnett, S. B., and Banghman, R. W. (1990). Intrastriatal grafts derived from fetal striatal primordia: II. Reconstruction of cholinergic and dopaminergic systems. J. Comp. Neurol.295:1–14. PubMed

Ludwin, S. K. (1985). Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. Lab. Invest.52:20–30. PubMed

Madrazo, I., Franco-Bourland, R. E., Castrejon, H., Cuevas, C., and Ostrosky-Solis, F. (1995). Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol. Res.17:312–315. PubMed

Mathewson, A. J., and Berry, M. (1985). Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res.18:61–69. PubMed

Mazurová, Y., Valoušková, V., Österreicher, J. (2002). The reaction of subependymal layer of the lateral brain ventricles to the striatal ibotenic acid lesion in long-term study. Acta Histochem.104(4):375–379. PubMed

Murabe, Y., Ibata, Y., and Sano, Y. (1981). Morphological studies on neuroglia. II. Response of glial cells to kainic acid-induced lesions. Cell Tissue Res.216:569–580. PubMed

Ogawa, M., Araki, M., Nagatsu, I., and Yoshida, M. (1989). Astroglial cell alteration caused by neurotoxins: immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase. Exp. Neurol.106:187–196. PubMed

Peschanski, M., Bachoud-Lévi, A. C., and Hantraye, P. (2004). Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain127:1219–1228. PubMed

Pritzel, M., Isacson, O., Brundin, P., Wiklund, L., and Björklund, A. (1986). Afferent and efferent connections of striatal grafts implanted into the ibotenic acid-lesioned neostriatum in adult rats. Exp. Brain Res.65:112–126. PubMed

Roberts, R. C., and DiFiglia, M. (1989). Short- and long-term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: a light and electron microscopic study. Synapse3:363–371. PubMed

Rosser, A. E., and Dunnett, S. B. (2003). Neural Transplantation in patients with Huntington's disease. CNS Drugs17:853–867. PubMed

Schiffer, D., Giordana, M. T., Cavalla, P., Vigliani, M. C., and Attanasio, A. (1993). Immunohistochemistry of glial reaction after injury in the rat: double stainings and markers of cell proliferation. Int.. J. Dev. Neurosci.11:269–280. PubMed

Schwarcz, R., Hökfeld, T., Fuxe, K., Jonsson, G., Goldstein, M., and Terenius, L. (1979). Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp. Brain Res.37:199–216. PubMed

Sortwell, C. E., Camargo, M. D., Pitzer, M. R., Gvawali, S., and Collier, T. J. (2001). Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol.169(1):23–29. PubMed

Šramka, M., Rattaj, M., Molina, H., Vojtassak, J., Belan, V., and Ružický, E. (1992). Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotact. Funct. Neurosurg.58:79–83. PubMed

Takamiya, Y., Kohsaka, S., Toya, S., Otani, M., and Tsukada, Y. (1988). Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Brain Res.466:201–210. PubMed

Teismann, P., Tieu, K., Cohen, O., Choi, D. K., Wu du, C., Marks, D., Vila, M., Jackson-Lewis, V., and Przedborski, S. (2003). Pathogenic role of glial cells in Parkinson's disease. Mov. Disord.18:121–129. PubMed

Watts, C., and Dunnett, S. B. (1998). Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. J. Neurosurg.89(2):267–274. PubMed

Wictorin, K. (1992). Anatomy and connectivity of intrastriatal striatal transplants. Prog. Neurobiol.38:611–639. PubMed

Transgenic rat model of Huntington's disease: a histopathological study and correlations with neurodegenerative process in the brain of HD patients